Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Sorokin

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Neuropathology and Applied Neurobiology|April 29, 1998
Differential labelling of laminin alpha 2 in muscle and neural tissue of dy/dy mice: are there isoforms of the laminin alpha 2 chain?C A Sewry, Y Uziyel, S Torelli, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|November 22, 2017
The gelatinases, MMP-2 and MMP-9, as fine tuners of neuroinflammatory processesM-J Hannocks, X Zhang, H Gerwien, et al.
Vestnik Oftalmologii|May 18, 2018
[Selection of optimal method of general anesthesia for intubation of nasolacrimal duct in young children]E A Bachinin, S I Utkin, E L Sorokin, et al.
Biochemistry. Biokhimiia|April 13, 2005
Inhibition of peroxidase-catalyzed oxidation of 3,3 ,5,5 -tetramethylbenzidine by aminophenolsI V Naumchik, E I Karasyova, D I Metelitza, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Synthesis and properties of 11-(3,5-di-tert-butyl-2-hydroxyphenylcarbamoyl)undecanoic acid, a new amphiphilic antioxidantVladimir I Lodyato, Irina L Yurkova, Viktor L Sorokin, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Novel (3,5-di-tert-butyl-2-hydroxy-phenylcarbamoyl)-alkanoic acids as potent antioxidantsVladimir I Lodyato, Irina L Yurkova, Viktor L Sorokin, et al.
Biomeditsinskaia Khimiia|December 15, 2007
[Substituted aminophenols and flavonoids as potential components for test-systems of total antioxidant activity]Iu A Grigorenko, E I Karaseva, D I Metelitsa, et al.
Neuromuscular Disorders : NMD|May 1, 1997
Variable clinical phenotype in merosin-deficient congenital muscular dystrophy associated with differential immunolabelling of two fragments of the laminin alpha 2 chainC A Sewry, I Naom, M D'Alessandro, et al.
Blood|December 9, 2000
Characterization and functional analysis of laminin isoforms in human bone marrowU Siler, M Seiffert, S Puch, et al.
Journal of the Neurological Sciences|June 17, 1999
Secondary reduction of alpha7B integrin in laminin alpha2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscleR D Cohn, U Mayer, G Saher, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Neuropathology and Applied Neurobiology|April 29, 1998
Differential labelling of laminin alpha 2 in muscle and neural tissue of dy/dy mice: are there isoforms of the laminin alpha 2 chain?C A Sewry, Y Uziyel, S Torelli, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|November 22, 2017
The gelatinases, MMP-2 and MMP-9, as fine tuners of neuroinflammatory processesM-J Hannocks, X Zhang, H Gerwien, et al.
Vestnik Oftalmologii|May 18, 2018
[Selection of optimal method of general anesthesia for intubation of nasolacrimal duct in young children]E A Bachinin, S I Utkin, E L Sorokin, et al.
Biochemistry. Biokhimiia|April 13, 2005
Inhibition of peroxidase-catalyzed oxidation of 3,3 ,5,5 -tetramethylbenzidine by aminophenolsI V Naumchik, E I Karasyova, D I Metelitza, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Synthesis and properties of 11-(3,5-di-tert-butyl-2-hydroxyphenylcarbamoyl)undecanoic acid, a new amphiphilic antioxidantVladimir I Lodyato, Irina L Yurkova, Viktor L Sorokin, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Novel (3,5-di-tert-butyl-2-hydroxy-phenylcarbamoyl)-alkanoic acids as potent antioxidantsVladimir I Lodyato, Irina L Yurkova, Viktor L Sorokin, et al.
Biomeditsinskaia Khimiia|December 15, 2007
[Substituted aminophenols and flavonoids as potential components for test-systems of total antioxidant activity]Iu A Grigorenko, E I Karaseva, D I Metelitsa, et al.
Neuromuscular Disorders : NMD|May 1, 1997
Variable clinical phenotype in merosin-deficient congenital muscular dystrophy associated with differential immunolabelling of two fragments of the laminin alpha 2 chainC A Sewry, I Naom, M D'Alessandro, et al.
Blood|December 9, 2000
Characterization and functional analysis of laminin isoforms in human bone marrowU Siler, M Seiffert, S Puch, et al.
Journal of the Neurological Sciences|June 17, 1999
Secondary reduction of alpha7B integrin in laminin alpha2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscleR D Cohn, U Mayer, G Saher, et al.
Pageof 8